pre-miRNA Information
pre-miRNA hsa-let-7e   
Genomic Coordinates chr19: 51692786 - 51692864
Synonyms MIRNLET7E, hsa-let-7e, let-7e, MIRLET7E
Description Homo sapiens let-7e stem-loop
Comment The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-let-7e-3p
Sequence 53| CUAUACGGCCUCCUAGCUUUCC |74
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 5 19 + 51692842 22499667, 28550310, 29267965, 29165639 MiREDiBase
C-to-U 10 19 + 51692847 27229138 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs752517215 7 dbSNP
rs1395020078 16 dbSNP
rs1309971473 20 dbSNP
rs755693563 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol GPS1   
Synonyms COPS1, CSN1, SGN1
Description G protein pathway suppressor 1
Transcript NM_004127   
Other Transcripts NM_212492   
Expression
Putative miRNA Targets on GPS1
3'UTR of GPS1
(miRNA target sites are highlighted)
>GPS1|NM_004127|3'UTR
   1 GGGGTGAACCTTGGCCTCCAGGACATCTGCACCCCCTCCCCACCTCCACGGACCTCGGACCTCCAGGCGGCTCAGTGCTG
  81 CCTGCGGCCCAGCTAAGGGGCCTGGCCACTGGGTGCCACCCAGCCTGTGTGCCCTCCCTGGGGCTGAGGAGGCAGGCGGC
 161 TGCTAGTTGTGGCCCTTCCTGGAAGGAGAGGCCTGCAGGGCTCGACCCTGTGGGTTTCTGTCCCCAGGGAGCAGACTGTG
 241 CGGCACCCAGGCCCAGTGGCACCATTTCCCAGACCCCTCCTGTTCCCGCCTCAGTCAGGTGCAGACAAGTGGGCGGTGTC
 321 CATTAAAGAGCAGACTCAGCGTTAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ccuuucgauccUCCGGCAUAUc 5'
                     || |:||:|: 
Target 5' gggtgccacccAGCCTGTGTGc 3'
111 - 132 99.00 -9.10
2
miRNA  3' ccuUUCGAUCCUCCGGCAUAuc 5'
             |: | || :||| ||:|  
Target 5' tgcAGACAAGTGGGCGGTGTcc 3'
300 - 321 95.00 -9.70
3
miRNA  3' ccUUUC--GA--UCCU---CCGGCAUAUc 5'
            |:||  ||  |||:   | || |:|: 
Target 5' ggAGAGGCCTGCAGGGCTCGACCCTGTGg 3'
185 - 213 88.00 -17.90
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30476736 2 COSMIC
COSN30523209 15 COSMIC
COSN24305993 22 COSMIC
COSN505936 37 COSMIC
COSN24034315 57 COSMIC
COSN13755347 58 COSMIC
COSN31556418 64 COSMIC
COSN26646699 65 COSMIC
COSN30535429 74 COSMIC
COSN30713175 79 COSMIC
COSN30182247 84 COSMIC
COSN26678630 88 COSMIC
COSN26636534 124 COSMIC
COSN30609352 139 COSMIC
COSN31578828 215 COSMIC
COSN15665798 224 COSMIC
COSN31561884 242 COSMIC
COSN31588918 289 COSMIC
COSN26637839 302 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1403609218 2 dbSNP
rs773849713 5 dbSNP
rs759173118 10 dbSNP
rs764779002 11 dbSNP
rs1174415373 17 dbSNP
rs1430122459 21 dbSNP
rs1296346105 22 dbSNP
rs752328214 23 dbSNP
rs762622123 25 dbSNP
rs1283088177 26 dbSNP
rs1343305167 27 dbSNP
rs1186481271 28 dbSNP
rs140755185 31 dbSNP
rs751301684 33 dbSNP
rs984435916 34 dbSNP
rs757193775 36 dbSNP
rs369830273 37 dbSNP
rs1264652350 39 dbSNP
rs1488606670 40 dbSNP
rs750349647 41 dbSNP
rs756198329 42 dbSNP
rs760497815 43 dbSNP
rs75363570 44 dbSNP
rs749504466 45 dbSNP
rs1442233984 48 dbSNP
rs57800087 50 dbSNP
rs779148528 51 dbSNP
rs1307900535 55 dbSNP
rs150111604 57 dbSNP
rs138450617 58 dbSNP
rs1356770986 62 dbSNP
rs184414541 64 dbSNP
rs769215319 65 dbSNP
rs1303059561 66 dbSNP
rs775020127 69 dbSNP
rs763739435 70 dbSNP
rs1463819658 71 dbSNP
rs1275766272 73 dbSNP
rs773990493 74 dbSNP
rs12841 83 dbSNP
rs761657065 86 dbSNP
rs767279761 87 dbSNP
rs750401131 90 dbSNP
rs111309938 91 dbSNP
rs766382520 95 dbSNP
rs926203424 96 dbSNP
rs936298385 100 dbSNP
rs753888910 101 dbSNP
rs563848936 102 dbSNP
rs779334656 104 dbSNP
rs946010907 106 dbSNP
rs1157075639 113 dbSNP
rs764051315 114 dbSNP
rs879464806 116 dbSNP
rs1162665697 119 dbSNP
rs1045834282 121 dbSNP
rs1389241489 122 dbSNP
rs758871614 124 dbSNP
rs1324682177 128 dbSNP
rs1335517983 130 dbSNP
rs1179222774 132 dbSNP
rs1444215699 132 dbSNP
rs1310986249 138 dbSNP
rs1250580223 139 dbSNP
rs778239246 139 dbSNP
rs1240186456 146 dbSNP
rs78625180 153 dbSNP
rs771415364 158 dbSNP
rs774871104 159 dbSNP
rs1232142994 161 dbSNP
rs749957833 167 dbSNP
rs1210327320 168 dbSNP
rs1272110564 171 dbSNP
rs1456266762 174 dbSNP
rs1338230321 176 dbSNP
rs947859568 176 dbSNP
rs570009667 177 dbSNP
rs1240264340 179 dbSNP
rs1374430956 182 dbSNP
rs1046582958 185 dbSNP
rs1440507602 187 dbSNP
rs1186955738 188 dbSNP
rs1397324300 189 dbSNP
rs761612913 192 dbSNP
rs765850933 192 dbSNP
rs1459937137 193 dbSNP
rs1164343007 197 dbSNP
rs1400102861 198 dbSNP
rs1366821025 199 dbSNP
rs1464407615 200 dbSNP
rs1033546082 203 dbSNP
rs768040376 204 dbSNP
rs774041060 205 dbSNP
rs1310019746 209 dbSNP
rs1469701064 214 dbSNP
rs1341736883 220 dbSNP
rs1245503778 221 dbSNP
rs761425733 224 dbSNP
rs10013 226 dbSNP
rs1017250004 228 dbSNP
rs1213038380 230 dbSNP
rs961084048 233 dbSNP
rs751103779 237 dbSNP
rs537465571 239 dbSNP
rs1458418579 241 dbSNP
rs994212437 242 dbSNP
rs555445570 243 dbSNP
rs766405936 247 dbSNP
rs1188270419 250 dbSNP
rs1174465064 251 dbSNP
rs955161426 256 dbSNP
rs985175392 263 dbSNP
rs911416337 265 dbSNP
rs1018086001 268 dbSNP
rs1477106444 271 dbSNP
rs1454425486 274 dbSNP
rs919993560 274 dbSNP
rs765351326 275 dbSNP
rs957523289 276 dbSNP
rs990430814 278 dbSNP
rs1447394647 280 dbSNP
rs753704934 281 dbSNP
rs976840976 285 dbSNP
rs1403827817 288 dbSNP
rs755133243 289 dbSNP
rs1449809087 290 dbSNP
rs967372961 291 dbSNP
rs1328845123 292 dbSNP
rs1338360648 300 dbSNP
rs1283411726 302 dbSNP
rs765374367 303 dbSNP
rs1046110129 304 dbSNP
rs752995777 307 dbSNP
rs977456676 308 dbSNP
rs1232889161 313 dbSNP
rs1254500296 315 dbSNP
rs1484322784 316 dbSNP
rs866310333 317 dbSNP
rs563587647 320 dbSNP
rs1320682454 321 dbSNP
rs750469449 322 dbSNP
rs1196432695 323 dbSNP
rs1424861294 329 dbSNP
rs937446842 332 dbSNP
rs1436847487 334 dbSNP
rs1432981403 336 dbSNP
rs1375776952 340 dbSNP
rs117705554 341 dbSNP
rs778300415 342 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Article - Leppert U; Henke W; Huang X; Muller JM; Dubiel W
- Journal of molecular biology, 2011
The COP9 signalosome (CSN) complex controls protein degradation via the ubiquitin (Ub) proteasome system (UPS) in eukaryotes. In mammalian cells, the multimeric CSN is composed of eight subunits (CSN1 - CSN8). It regulates cullin-RING Ub ligases (CRLs), which target essential regulatory proteins for ubiquitination and subsequent degradation. Thereby, the CSN cooperates with the UPS in a variety of essential cellular functions, including DNA repair, cell cycle and differentiation. Although functions of the CSN have been elucidated, mechanisms and regulatory principles of its de novo formation are completely unknown. Here, we show that there is a fundamental mechanism that allows a coordinated expression of all CSN subunits, a prerequisite for CSN assembly. CSN subunit mRNAs are targets of miRNAs of the let-7 family suppressing CSN subunit expression in human cells. Factors that reduce or block let-7 miRNAs induce the coordinated expression of CSN subunits. For instance, over-expression of CSN1 specifically traps let-7a-1 miRNA and elevates CSN subunit levels by two- to fourfold in a coordinated manner. CSN subunit expression is also increased by specific miRNA inhibitors or by interferon (IFN)-mediated induction of STAT1 and c-Myc reducing levels of let-7 miRNAs. Activation of STAT1 by IFNalpha or IFNgamma induces c-Myc, which increases CSN subunit expression via the Lin28B/let-7 regulatory pathway. By contrast, a let-7a-1 mimic reduces CSN subunit expression. Our data show that let-7 miRNAs control the fine-tuning and coordinated expression of subunits for CSN de novo formation, presumably a general regulatory principle for other Zomes complexes as well.
LinkOut: [PMID: 21530537]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
KIRP -0.403 0.01 -0.357 0.02 32 Click to see details
BRCA -0.209 0.03 -0.129 0.12 84 Click to see details
LIHC -0.209 0.07 -0.246 0.04 49 Click to see details
PCPG -0.951 0.1 -0.500 0.33 3 Click to see details
CHOL -0.422 0.13 -0.350 0.18 9 Click to see details
UCEC -0.259 0.14 -0.128 0.3 19 Click to see details
CESC 0.859 0.17 0.500 0.33 3 Click to see details
THCA 0.115 0.19 0.025 0.43 59 Click to see details
PAAD -0.42 0.29 0.200 0.4 4 Click to see details
LUAD -0.15 0.32 -0.112 0.36 12 Click to see details
LUSC -0.071 0.34 -0.292 0.04 38 Click to see details
STAD -0.077 0.34 -0.187 0.15 32 Click to see details
ESCA -0.108 0.38 -0.091 0.4 11 Click to see details
KIRC -0.036 0.39 -0.154 0.1 68 Click to see details
COAD 0.085 0.42 -0.143 0.37 8 Click to see details
PRAD -0.028 0.42 -0.051 0.36 50 Click to see details
KICH -0.031 0.44 -0.095 0.33 25 Click to see details
HNSC 0.015 0.46 0.054 0.37 42 Click to see details
BLCA -0.021 0.47 -0.098 0.35 18 Click to see details
BLCA -0.021 0.47 -0.098 0.35 18 Click to see details
BLCA -0.021 0.47 -0.098 0.35 18 Click to see details
15 hsa-let-7e-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT032094 COPS8 COP9 signalosome subunit 8 1 1
MIRT032096 GPS1 G protein pathway suppressor 1 1 1
MIRT032097 COPS6 COP9 signalosome subunit 6 1 1
MIRT038992 PHF23 PHD finger protein 23 1 1
MIRT055836 PLEKHA1 pleckstrin homology domain containing A1 2 10
MIRT106126 AGPAT5 1-acylglycerol-3-phosphate O-acyltransferase 5 2 2
MIRT227803 GTF3C4 general transcription factor IIIC subunit 4 2 2
MIRT472953 MSANTD3 Myb/SANT DNA binding domain containing 3 2 2
MIRT492137 SUMO2 small ubiquitin-like modifier 2 2 6
MIRT687915 HOOK3 hook microtubule tethering protein 3 2 2
MIRT711935 LINC00598 long intergenic non-protein coding RNA 598 2 2
MIRT734990 COL3A1 collagen type III alpha 1 chain 1 0
MIRT734991 ACVR1B activin A receptor type 1B 1 0
MIRT734992 CASP3 caspase 3 1 0
MIRT736470 ALOX5 arachidonate 5-lipoxygenase 1 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
let-7e Docosahexaenoic acid NULL 445580 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
let-7e Hydroxamic acid HDACi LAQ824 NULL NULL Microarray breast cancer cell line SKBr3 16452179 2006 down-regulated
let-7e Doxorubicin approved 31703 Microarray ovarian cancer 19237188 2009 up-regulated
let-7e 17beta-estradiol (E2) approved 5757 Microarray MCF-7 breast cancer cells 19528081 2009 up-regulated
let-7e Etoposide approved 36462 Microarray Normal human fibroblasts (AG01522) 19633716 2009 up-regulated
let-7e Formaldehyde NULL 712 Microarray Human lung epithelial cells (A549) 21147603 2011 down-regulated
let-7e 5-Fluorouracil approved 3385 Microarray MCF-7 breast cancer cells 21506117 2011 down-regulated
let-7e Bicalutamide approved 2375 Microarray prostate 22674191 2012 up-regulated
let-7e Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse brain 19270793 2009 up-regulated
let-7e Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse liver 19270793 2009 down-regulated
let-7e 17beta-estradiol (E2) approved 5757 Microarray rat breast 17700064 2007 down-regulated
let-7e Marine fungal metabolite 1386A NULL NULL Microarray MCF-7 breast cancer cells. 22159329 2012 down-regulated
let-7e Ginsenoside Rh2 NULL 119307 Microarray NSCLC cell line A549 23152132 2013 down-regulated
let-7e 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) NULL 16078949 Microarray hepatocytes 23107762 2013 up-regulated
let-7e Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer cell line (A2780)
hsa-let-7e Doxorubicin 31703 NSC123127 approved resistant High Ovarian Cancer cell line (OV19, TOV21G, TOV112D, FUOV1, C13, OV2008, A2780CP, A2780S, IGROV1, T8, OVCAR5, IMCC3, A2008, OVCAR3, SKOV3, IOSER)
hsa-let-7e Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-let-7e Verapamil 2520 NSC272366 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-let-7e Cisplatin 5460033 NSC119875 approved resistant High Tongue Squamous Cell Carcinoma cell line (Tca8113)
hsa-let-7e Fluorouracil 3385 NSC19893 approved resistant High Colon Cancer cell line (DLD-1)
hsa-let-7e Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer tissue and cell line (A2780)
hsa-let-7e Oxaliplatin 6857599 NSC266046 approved resistant High Colorectal Cancer cell line (HT-29)
hsa-let-7e Paclitaxel 36314 NSC125973 approved sensitive High Pan-Cancer cell line (NCI-H460, NCI-H522, NCI-H322M, HOP62, A549, EKVX, MALME-3M, NCI-H226, HT-29, HCT-116, SE-620, HCT-15, HCC2998, COLO205, HS-578T, NCI/ADR-RES, OVCAR8, OVCAR4, ACHN, SN-12C, 786-O, CAKI-1, UO-31, TK-10, A498, SK-MEL-28, UACC-257, M14, UACC-62, SK
hsa-let-7e Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (H1155, H358, H1993)
hsa-let-7e Doxorubicin 31703 NSC123127 approved sensitive Low Gastric Cancer cell line (SGC7901)
hsa-let-7e Vincristine 5978 approved sensitive Low Gastric Cancer cell line (SGC7901)
hsa-let-7e Gefitinib 123631 NSC715055 approved sensitive High Lung Adenocarcinoma cell line (A549)
hsa-let-7e Imatinib 5291 NSC743414 approved resistant High Gastrointestinal Stromal Tumor tissue
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-let-7e Doxorubicin 31703 NSC123127 approved sensitive Low Breast Cancer tissue and cell line (MCF-7)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer cell line (A2780)
hsa-let-7e Plx-4720 24180719 NSC757438 resistant High Thyroid Cancer cell line (8505c, BCPAP)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-let-7e Fluorouracil 3385 NSC19893 approved sensitive High Colorectal Cancer cell line (DLD-1)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (A2780, HO8910, ES2, CAOV3, SKOV3)
hsa-let-7e Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HCT-8)
hsa-let-7e Daunorubicin 30323 NSC82151 approved resistant High Acute Promyelocytic Leukemia cell line (HL60)
hsa-let-7e Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7C)
hsa-let-7e Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-let-7e Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7)
hsa-let-7e Gefitinib 123631 NSC715055 approved sensitive Low Non-Small Cell Lung Cancer cell line (PC-9)
hsa-let-7e Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375)
hsa-let-7e Gefitinib 123631 NSC715055 approved sensitive Low Colorectal Cancer cell line (HCT-116)
hsa-let-7e Regorafenib 11167602 NSC763932 approved sensitive Low Colorectal Cancer cell line (HCT-116)
hsa-let-7e Ribavirin+Pegylated IFNa-2b resistant tissue (chronic hepatitis C)
hsa-let-7e Exemestane 60198 NSC713563 approved sensitive cell line (MCF-7)
hsa-let-7e 4-Hydroxytamoxifen+Tamoxifen resistant cell line (LY2)
hsa-let-7e Ethanol+Tamoxifen resistant cell line (LY2)
hsa-let-7e Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-let-7e Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-let-7e Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-let-7e Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-let-7e Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-let-7e Gemcitabine 60750 NSC613327 approved resistant cell line (HuH28)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive cell line (KYSE)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive cell line (OE19)
hsa-let-7e Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-let-7e Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-let-7e Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-let-7e Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-let-7e Cisplatin 5460033 NSC119875 approved sensitive cell line (H460)
hsa-let-7e Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine resistant cell line (Bats-72)
hsa-let-7e-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-let-7e-3p Verapamil 2520 NSC272366 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-let-7e-3p Oxaliplatin 6857599 NSC266046 approved resistant High Colorectal Cancer cell line (RKO)
hsa-let-7e-3p Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer tissue
hsa-let-7e-3p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-let-7e-3p Osimertinib 71496458 NSC779217 approved resistant cell line (HCC827)
hsa-let-7e-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-let-7e-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-let-7e-3p Tamoxifen 2733525 NSC180973 approved sensitive cell line (LCC2)
hsa-let-7e-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-let-7e-3p Fluorouracil 3385 NSC19893 approved resistant cell line (HCT15)
hsa-let-7e-3p Ethanol+Tamoxifen sensitive cell line (LY2)
hsa-let-7e-3p Sunitinib 5329102 NSC750690 approved sensitive tissue (CardB)
hsa-let-7e-3p Pegylated interferon alpha+Ribavirin resistant tissue (chronic hepatitis C)
hsa-let-7e-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-let-7e-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)

Error report submission